1 May 2006   
News
Executive Vice President's Message
Expression of Measurement Uncertainty in Laboratory Medicine (C51-P)
Volunteer Focus
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Events and Exhibits
Upcoming Events
Upcoming Presentations
CLSI Meetings Calendar
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Subscription
 
CLSI Home Page
Search Past Issues
Update Your Contact Information
Print this article Print all articles
 
 
 
Winner of the Silver Award for Patient Education in the WWW Health Awards Program

Recently Approved Documents
Remote Access to Clinical Laboratory Diagnostic Devices via the Internet (AUTO9-A); Laboratory Documents: Development and Control (GP2-A5); Quality Assurance of Laboratory Tests for Autoantibodies to Nuclear Antigens (I/LA2-A2)

 Second Notice

AUTO9-ARemote Access to Clinical Laboratory Diagnostic Devices via the Internet;
Approved Standard
This document provides a standard communication protocol that will allow remote connections to laboratory devices, which can be used to monitor the instruments' subsystems to determine proper operation; collect diagnostic data for remote system troubleshooting; and collect data that would allow for electronic inventory management.
Purchase here.

GP2-A5Laboratory Documents: Development and Control; Approved Guideline—Fifth Edition
This guideline presents the important components of writing and managing documents for the clinical laboratory. This guideline describes common and specific sections for inclusion in laboratory documents. Several examples of process and procedure documents for preexamination, examination, and postexamination laboratory activities are provided in the form of appendixes; such appendixes are simply illustrative, and not prescriptive.
Purchase here.

I/LA2-A2Quality Assurance of Laboratory Tests for Autoantibodies to Nuclear Antigens: (1) Indirect Fluorescence Assay for Microscopy and (2) Microtiter Enzyme Immunoassay Methods: Approved Guideline—Second Edition
This document addresses the criteria for ANA testing by immunofluorescence and by enzyme immunoassay, including test components, quantification of results, and classification criteria.
Purchase here.


Our procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community that participates in the consensus process by carefully reviewing and commenting on the standard or guideline.

You may automatically receive or select approved-level documents as a member benefit.  Find out more about joining CLSI:  view membership options and benefits. [ return to top ]

For more information or to contact us directly, please visit www.clsi.org
©2005 Clinical and Laboratory Standards Institute